Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Antibiotic resistance, particularly from vancomycin-resistant Enterococcus faecium (VRE), poses a significant global health threat.
• VRE infections are increasingly prevalent in intensive care units, necessitating novel therapeutic strategies.

Purpose of the Study:

• To synthesize and evaluate a novel class of 1,2,4-triazolo[1,5-a]pyrimidines for antimicrobial activity against VRE.
• To identify the mechanism of action for these novel compounds.

Main Methods:

• A Biginelli-like three-component heterocyclization reaction was employed to synthesize 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
• Antimicrobial activity was assessed against the ESKAPE panel, with a focus on E. faecium.
• In vitro assays, including metabolic stability and macromolecular synthesis studies, were conducted.

Main Results:

• A subset of 1,2,4-triazolo[1,5-a]pyrimidines demonstrated potent, narrow-spectrum activity against E. faecium.
• These compounds exhibited favorable metabolic stability and low intrinsic clearance.
• Macromolecular synthesis assays indicated that cell-wall biosynthesis is the primary target.

Conclusions:

• The novel 1,2,4-triazolo[1,5-a]pyrimidines represent a promising new class of antibiotics against VRE.
• Their targeted mechanism of action on cell-wall biosynthesis warrants further investigation for clinical development.